Latest news
Gradient Investments LLC Makes New Investment in Halozyme Therapeutics, Inc. $HALO - MarketBeatMarketBeat · Mon, 10 Aug 2026 09:27:27 GMTHalozyme Therapeutics (NASDAQ:HALO) Upgraded to Strong-Buy at Wall Street Zen - MarketBeatMarketBeat · Sat, 08 Aug 2026 07:55:11 GMTHalozyme Therapeutics (NASDAQ:HALO) Given New $105.00 Price Target at TD Cowen - MarketBeatMarketBeat · Fri, 07 Aug 2026 21:22:29 GMTCitizens Jmp Raises Halozyme Therapeutics (NASDAQ:HALO) Price Target to $93.00 - MarketBeatMarketBeat · Fri, 07 Aug 2026 15:45:58 GMTHalozyme Therapeutics (NASDAQ:HALO) Upgraded to "Outperform" at Leerink Partners - MarketBeatMarketBeat · Fri, 07 Aug 2026 13:09:51 GMTHalozyme Therapeutics (NASDAQ:HALO) Releases FY 2026 Earnings Guidance - MarketBeatMarketBeat · Thu, 06 Aug 2026 23:10:37 GMTCooper Investors PTY Ltd. Acquires New Shares in Halozyme Therapeutics, Inc. $HALO - MarketBeatMarketBeat · Wed, 05 Aug 2026 08:13:58 GMTEdgestream Partners L.P. Sells 55,915 Shares of Halozyme Therapeutics, Inc. $HALO - MarketBeatMarketBeat · Sun, 02 Aug 2026 07:00:00 GMT